key articles
Schedule and duration of intravesical chemotherapy for non-muscle-invasive bladder cancer patients
Wednesday, 20 February 2008 - Optimal schedule and duration of Intravesical chemotherapy are unknown. Sylvester et al. (2008) determined the effect of schedule and duration of intravesical chemotherapy on recurrence in patients...
Authors: Sylvester et al.
Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer
Monday, 18 February 2008 - Because of controversial risk factors for progression, recurrence, and persistence of bladder cancer, Schulze et al. (2007) reviewed the data of their patients with superficial bladder tumours. Based on...
Authors: Schulze et al.
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy
Wednesday, 14 February 2008 - The presence of a systemic inflammatory response is associated with poor survival in various malignancies. A high C-reactive protein (CRP) level is a poor prognostic indicator in patients with renal...
Authors: Yoshida et al.
The changing patterns of bladder cancer in Egypt over the past 26 years
Thursday, 14 February 2008 - Felix et al. (2008) evaluated temporal changes in histopathological types of bladder cancer in Egypt and to assess associated changes in demographic, epidemiologic, and lifestyle risk factors.
The...
Authors: Felix et al.
Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform
Friday, 8 February 2008 - Bladder cancer (BCa) is one of the most prevalent malignancies worldwide, mostly due to its high recurrence rates. In consequence, the necessity of repeated screening for reappearance demonstrates the...
Authors: Schiffer et al.
The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies
Thursday, 7 February 2008 - Raitanen (2008) summarized the results of the FinnBladder studies of the BTA stat Test in follow-up of bladder cancer and more importantly to provide guidelines for daily clinical practise.
Voided...
Author: Raitanen
Urinary Markers in Bladder Cancer - Review
Thursday, 31 January 2008 - Many markers for the detection of bladder cancers have been tested. Almost all urinary markers reported are better than cytology with regard to sensitivity, but they score lower in specificity. In a...
Authors: Vrooman & Witjes
Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
Thursday, 31 January 2008 - The clinical management of non-muscle-invasive urothelial cell carcinoma of the bladder (UCC) is challenging, as it has a marked tendency to recur and to progress. Burger et al. (2007) studied the...
Authors: Burger et al.
Molecular markers in bladder cancer
Saturday, 26 January 2008 - Bladder cancer is a diverse disease whose molecular phenotypes are being elucidated. In a review, Shariat et al. (2008) summarized currently known molecular pathways and associated markers in bladder...
Authors: Shariat et al.
Bladder cancer: can imaging change patient management?
Wednesday, 23 January 2008 - Bladder cancer is the fourth most common malignancy in men and the ninth most common malignancy in women. Recent technical advances have an impact on the management of patients with bladder cancer. In...
Authors: Beyersdorff et al.
